We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

FDA Asks GSK, Others For Data On Asthma Drugs

Law360 (March 6, 2008, 12:00 AM EST) -- The U.S. Food and Drug Administration has requested additional information from several asthma-drug makers, including GlaxoSmithKline and Novartis AG, in order to conduct further review of the drugs' safety.

The FDA said in a statement Wednesday that it asked the drugmakers in January for information about controlled clinical studies conducted on the products, known as long-acting beta agonists.

The drugs the agency has requested information on are GlaxoSmithKline's Advair and Serevent, Novartis AG's Foradil, AstraZeneca's Symbicort, Mylan Inc.'s Perforomist and Sepracor Inc.'s Brovana.

The companies indicated...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.